About the Authors
- Konstantinos A. Polyzos
-
Affiliation Alfa Institute of Biomedical Sciences (AIBS), Athens, Greece
- Michael N. Mavros
-
Affiliation Alfa Institute of Biomedical Sciences (AIBS), Athens, Greece
- Konstantinos Z. Vardakas
-
Affiliation Alfa Institute of Biomedical Sciences (AIBS), Athens, Greece
- Marinos C. Makris
-
Affiliation Alfa Institute of Biomedical Sciences (AIBS), Athens, Greece
- Petros I. Rafailidis
-
Affiliations Alfa Institute of Biomedical Sciences (AIBS), Athens, Greece, Department of Medicine, Henry Dunant Hospital, Athens, Greece
- Matthew E. Falagas
-
* E-mail: m.falagas@aibs.gr
Affiliations Alfa Institute of Biomedical Sciences (AIBS), Athens, Greece, Department of Medicine, Henry Dunant Hospital, Athens, Greece, Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts, United States of America
Competing Interests
MEF has participated on the advisory boards of Astellas, Bayer, and Pfizer and has received lecture honoraria from Astellas, AstraZeneca, Cipla, Glenmark, Merck, Novartis, and Pfizer. All other authors report no potential conflicts.
Author Contributions
Analyzed the data: KAP MNM KZV MCM PIR MEF. Wrote the paper: KAP MEF. Designed the study: KAP MEF. Collected the data: KAP MNM MCM. Revised the manuscript: KAP MNM KZV MCM PIR MEF. Approved the final version of the manuscript: KAP MNM KZV MCM PIR MEF.